Berliner Tageszeitung - Ex-security chief 'betrayed' Mexico, drugs trial hears

NYSE - LSE

RBGPF	0%	60.72	$
BCC	0.63%	71.59	$
RIO	0.51%	105.89	$
NGG	-0.33%	81.57	$
CMSD	0.27%	22.32	$
GSK	-1.55%	52.23	$
CMSC	0.04%	22.34	$
BCE	-0.99%	24.04	$
BP	-2.86%	41.59	$
BTI	-2.06%	61.06	$
RELX	-2.74%	32.84	$
JRI	0.89%	12.78	$
VOD	-3.53%	15	$
RYCEF	2.63%	17.5	$
AZN	-0.83%	177.27	$

Ex-security chief 'betrayed' Mexico, drugs trial hears

BOULEVARD 23.01.2023

A once-powerful Mexican government minister "betrayed" his country by engaging in the very drug trafficking he was in charge of stopping, US prosecutors told his trial Monday.

Text size:

Genaro Garcia Luna is accused of receiving vast sums of money to allow the notorious Sinaloa cartel to smuggle cocaine when he was public security minister between 2006 and 2012.

"The defendant took millions of dollars of bribes again, again and again," government attorney Philip Pilmar said in opening arguments at Brooklyn federal court.

"He is a man who betrayed his country and ours," added the prosecutor, as the 54-year-old Garcia Luna looked on from the dock, sometimes blowing kisses to his wife and daughter.

Garcia Luna has pleaded not guilty to five counts that carry possible sentences of between 10 years and life in prison.

US prosecutors accuse him of looking the other way as drug lord Joaquin "El Chapo" Guzman's cartel shipped tons of drugs into the United States between 2001 and 2012.

Guzman is currently serving a life sentence in the United States after being convicted by a jury in Brooklyn in 2019.

The US government alleges that Garcia Luna became a member of Sinaloa around January 2001 when he was working in police intelligence.

From 2006 to 2012 he was the architect of then-president Felipe Calderon's crackdown on Mexico's drug gangs.

But prosecutors say that in exchange for millions of dollars, Garcia Luna agreed not to interfere with drug shipments, tipped off traffickers about law enforcement operations, targeted rival cartel members for arrest and placed other corrupt officials in positions of power.

A former Sinaloa member said at Guzman's trial that he had delivered suitcases containing at least $6 million in cash to Garcia Luna at a restaurant in 2005, 2006 and 2007.

Garcia Luna's defense team has indicated it will argue that their client was actually helping the US Drug Enforcement Administration (DEA).

"No money, no photos, no video, no recording, no text, no evidence that Garcia Luna helped the cartel," attorney Cesar de Castro said during opening arguments by the defense.

Garcia Luna was detained in Texas in December 2019. He is also accused of lying when he applied for US citizenship in 2018.

The current Mexican government, which has requested Garcia Luna's extradition from the United States, has accused him of stealing more than $200 million of public funds.

His New York trial is expected to last eight weeks.

O. Larsen--BTZ

Featured

'They want to destroy us': Shock and anger as Russian attack sets Kyiv cathedral ablaze

Father Makariy, a high-ranking clergyman at Kyiv's Pechersk Lavra monastery complex, was woken at around 5:00 am with a huge roar -- the cathedral at the heart of one of Orthodox Christianity's most important sites had been set on fire in a Russian attack.

Burnt-out Indonesians beat the blues with children's games

Flushed and sweating, 31-year-old Annisa Enggracia Fidel runs back and forth to defend her fort from invaders -- hundreds of fellow adults all beating the blues by playing a nostalgic Indonesian children's game.

Greek fishermen struggle to keep up with pufferfish invaders

On his fishing boat moored in the Greek port of Ierapetra in southwestern Crete, Alexis Charlambakis pries open the mouth of a freshly-caught pufferfish to reveal two massive teeth on each jaw.

BioNxt Engages Business Development & Licensing Advisors for Commercialization of Patented Sublingual Cladribine ODF

VANCOUVER, BC / ACCESS Newswire / June 15, 2026 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery systems, is pleased to announce that it has commenced work with a Business Development & Licensing ("BD&L") specialist advisor to support the commercialization and partnering strategy for BNT23001, the Company's patented proprietary sublingual Cladribine orally dissolvable film ("ODF") formulation for the treatment of multiple sclerosis ("MS").